Senior insider sale
SVP, General Counsel at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$1.69M
3.74K shares
What this filing means
LIU JOY plans to sell 3.74K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $1.69M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/1/2026ACC: 0001959173-26-005009
Officer· SVP, General Counsel
Since Mar 2021
3.74K
Shares to sell
$1.69M
Approx. market value
828.00
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
2/26/2025
828.00Total acquired828.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/26/2025 | Restricted Stock Vesting Compensation | 828.00 | — |
| Total | 828.00 | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
828.00
Market value
$364.2K
6/1/2026
—Completed
Units to sell
1.10K
Market value
$469.2K
5/1/2026
—Completed
Units to sell
978.00
Market value
$439.3K
4/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
828.00
Market value
$416.2K
7/1/2026
Total
Units
3.74K
Value
$1.69M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/1/2026 | 828.00 | $364.2K | — | Completed |
5/1/2026 | 1.10K | $469.2K | — | Completed |
4/1/2026 | 978.00 | $439.3K | — | Completed |
| Planned — Approximate Date | ||||
7/1/2026 | 828.00 | $416.2K | NASDAQ | Planned |
| Total | 3.74K | $1.69M | ||